1. President Trump readying drug pricing executive orders — Roche Tecentriq-Avastin combo fails to hit primary endpoint in ovarian cancer trial — Moderna's COVID vaccine could see $5B or more in sales, say analysts — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

HUGO > NoGo

Discussion in 'Covidien' started by anonymous, Feb 27, 2018 at 11:35 AM.

  1. anonymous

    anonymous Guest

    if you think it's bad now with the robot taking more and more energy/ stapling business, wait until the bottom feeder Applied enters the stapling market. Your skills and relationships will be devalued more than they already are.
     
  2. anonymous

    anonymous Guest

    The thought of an Applied Medical stapler scares the shit out of me...not as a rep, but as a potential patient.
     
  3. anonymous

    anonymous Guest


    AGREED
     
  4. anonymous

    anonymous Guest

    Why don't they produce their own sutures?
     
  5. anonymous

    anonymous Guest

    Hugo software development and integration challenges: “that took us a bit longer and set us back as well”. And “COVID has limited the pace at which we can really complete the required software system in pre-clinical testing”. Bob White, MITG VP. See you in 2023 Hugo....